 VALENCIA, Calif., and MELBOURNE, Australia, July 25, 2022 GLOBE NEWSWIRE -- AVITA Medical, Inc. NASDAQ: RCEL, ASX: AVH, a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that it will release its second quarter 2022 financial results on Thursday, August 11, 2022. In conjunction with such release, the Company plans to host a conference call and webcast that day at 2:00 p.m. Pacific Time 5:00 p.m. Eastern Time Friday, August 12, 2022 at 7:00 a.m. Australian Eastern Standard Time to discuss its financial results and recent highlights. 